Oorsprong van het eerstegraads netwerk van Kevin P. Baker
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 32 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Kevin P. Baker via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Founder Founder | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | General Counsel Chief Executive Officer Human Resources Officer | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| Stanford University | College/University | Director/Board Member Doctorate Degree Doctorate Degree | |
| University of California, Davis | College/University | Graduate Degree Doctorate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Vanderbilt University | College/University | Doctorate Degree Graduate Degree | |
| ALECTOR, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| APEXIGEN, INC. | Biotechnology | Director of Finance/CFO President | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| University of Michigan | College/University | Masters Business Admin Masters Business Admin | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
UCSF Foundation
 UCSF Foundation Investment Trusts/Mutual FundsMiscellaneous The UCSF Foundation promotes and supports the interests and welfare of the University of California San Francisco and the UCSF Medical Center. The UCSF Foundation’s daily operations are administered by a development staff responsible for major gifts, planned giving, corporate and foundation gifts, annual giving, development communications, alumni relations and campus events | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| San Francisco State University | College/University | Undergraduate Degree Undergraduate Degree | |
| RAYZEBIO, INC. | Biotechnology | Chief Executive Officer Founder | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| CAREDX, INC | Medical Specialties | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Georgia Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Private Equity Investor | |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Founder | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ATRECA, INC. | Biotechnology | Director/Board Member Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder | |
| IQVIA HOLDINGS INC. | Services to the Health Industry | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
| TPG Biotechnology Partners LP | Investment Managers | Founder | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bay Way Consultants LLC | Founder | ||
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder |
Statistieken
Internationaal
| Verenigde Staten | 50 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 252 |
| Independent Dir/Board Member | 97 |
| Corporate Officer/Principal | 93 |
| Chairman | 41 |
| Chief Tech/Sci/R&D Officer | 32 |
Sterkste connecties
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Brook Byers | 53 |
| Franklin Berger | 41 |
| Brian Atwood | 39 |
| Mark McDade | 35 |
| William Ringo | 32 |
| Julia Gregory | 22 |
| Gail Maderis | 20 |
| Linda Rubinstein | 16 |
| Julie Hambleton | 15 |
| Garry Nicholson | 14 |
| Jeffrey Finer | 12 |
| Lorianne K. Masuoka | 12 |
| Min MIn Qin | 11 |
| Aron M. Knickerbocker | 11 |
- Beurs
- Insiders
- Kevin P. Baker
- Bedrijfsconnecties
